http://www.acc.org/Feed?clinicalTopicID=af87f19c-b38d-4ead-99f0-12dbb1291f20 Clinical Topic Feed: Aortic Surgery en /Latest-in-Cardiology/Articles/2026/06/01/01/Feature-Navigating-Valve-Disease Shared decision-making has become central to the management of valve disease, including tricuspid regurgitation (TR) (see cover story) and severe aortic stenosis (AS). If done correctly, it can help clinicians engage patients and families in meaningful discussions about symptoms, prognosis, treatment burden and personal goals... 1780316280000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/01/01/Peripheral-Matters-Lower-Extremity-Atherectomy Peripheral artery disease (PAD) affects more than 12 million Americans and is a leading cause of limb loss and cardiovascular mortality. Atherectomy – the mechanical removal of atherosclerotic plaque – has emerged as an important adjunct to balloon angioplasty, stenting and drug delivery systems... 1780316100000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/01/01/Focus-on-Intervention The wave of coronary and structural heart intervention trials from last year is shifting how interventional cardiologists may approach patient care. Across multiple domains including coronary devices, revascularization strategies, lesion preparation and structural therapies, new data are challenging long-standing assumptions... 1780316040000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1780315620000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/26/13/15/Evolut-Low-Risk-Trial-Six-Year-Outcomes The Evolut Low Risk trial was a prospective randomized trial that enrolled patients at low surgical risk with severe trileaflet aortic stenosis from 87 international sites between 2016 and 2019. 1779899100000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/05/18/18/10/JACC-Journals-Science-From-EuroPCR-2026 Findings from four late-breaking clinical trials presented at EuroPCR 2026 in Paris, France, were simultaneously published in JACC: Cardiovascular Interventions. Together they lend new insights into residual tricuspid regurgitation (TR) after tricuspid valve transcatheter edge-to-edge repair (T-TEER), the safety of transfemoral (TF) transcatheter mitral valve replacement (TMVR), the novel BATMAN-TMVR technique, and the effect of implant depth on TAVR outcomes. 1779371700000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/20/13/40/eagles-eye-view-20may2026 In this week’s View, Dr. Eagle reviews evidence supporting the use of cardiac magnetic resonance (CMR) and NT-proBNP in hypertrophic cardiomyopathy (HCM) risk assessment. 1779288780000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/04/28/20/06/noble No significant difference was observed in all-cause mortality at 10 years between PCI and CABG in patients with unprotected left main coronary artery disease (CAD) and no additional complex lesions, according to the final results of the NOBLE study published April 4 in The Lancet. 1777412340000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/21/15/23/ACC26-Structural-Intervention-Trials-Offer-Viable-Options Late-breaking clinical trials presented at ACC.26 focusing on structural interventions included the PROTECT H2H trial comparing two embolic protection devices (EPDs) in patients undergoing transcatheter aortic valve implantation (TAVI), the PRO-TAVI trial comparing a strategy of routine PCI with a deferred approach... 1776939000000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/22/13/48/eagles-eye-view-22apr2026 In this week’s Eagle's Eye View, Dr. Eagle examines early surgery for asymptomatic patients with severe aortic stenosis. 1776865800000 Articles and Stories